GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 44.15 |
| Open | 44.62 |
| Bid | 45.78 x 4000 |
| Ask | 0.00 x 1800 |
| Day's range | 44.59 - 45.84 |
| 52-week range | 33.53 - 46.86 |
| Volume | |
| Avg. volume | 4,161,006 |
| Market cap | 115.077B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 19.85 |
| EPS (TTM) | 2.30 |
| Earnings date | 01 Feb 2017 - 06 Feb 2017 |
| Forward dividend & yield | 2.20 (4.98%) |
| Ex-dividend date | 18 Nov 2021 |
| 1y target est | 48.38 |
- Zacks
Gilead's (GILD) Magrolimab Studies Put on Hold by the FDA
Gilead (GILD) efforts to build an oncology franchise get jolted as the FDA places hold on a few studies evaluating the combination of magrolimab plus azacitidine.
- Zacks
Glaxo's (GSK) New Drugs Drive Sales Amid Rising Competition
Glaxo (GSK) has made significant progress in its pipeline. Several new drug/line extension approvals are expected in 2022, which should boost the top line in the long term.
- Zacks
SAB Biotherapeutics (SABS) Posts Data From COVID Treatment Study
Following positive data from phase II study, SAB Biotherapeutics (SABS) starts a phase III study evaluating its COVID antibody treatment.
© 2022 Yahoo. All rights reserved.
